These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 35190921)

  • 21. Can Beta-2-Adrenergic Pathway Be a New Target to Combat SARS-CoV-2 Hyperinflammatory Syndrome?-Lessons Learned From Cancer.
    Barbieri A; Robinson N; Palma G; Maurea N; Desiderio V; Botti G
    Front Immunol; 2020; 11():588724. PubMed ID: 33117402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokines and COVID-19: friends or foes?
    Rokni M; Hamblin MR; Rezaei N
    Hum Vaccin Immunother; 2020 Oct; 16(10):2363-2365. PubMed ID: 32841579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel mediators and mechanisms in the resolution of infectious inflammation: evidence for vagus regulation.
    Serhan CN; de la Rosa X; Jouvene C
    J Intern Med; 2019 Sep; 286(3):240-258. PubMed ID: 30565762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lung innervation in the eye of a cytokine storm: neuroimmune interactions and COVID-19.
    De Virgiliis F; Di Giovanni S
    Nat Rev Neurol; 2020 Nov; 16(11):645-652. PubMed ID: 32843733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Use of Specialized Pro-Resolving Mediators in Biomaterial-Based Immunomodulation.
    Sousa AB; Barbosa JN
    J Funct Biomater; 2023 Apr; 14(4):. PubMed ID: 37103313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resolution of Inflammation after Skeletal Muscle Ischemia-Reperfusion Injury: A Focus on the Lipid Mediators Lipoxins, Resolvins, Protectins and Maresins.
    Barnig C; Lutzweiler G; Giannini M; Lejay A; Charles AL; Meyer A; Geny B
    Antioxidants (Basel); 2022 Jun; 11(6):. PubMed ID: 35740110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets.
    Kumar V
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107087. PubMed ID: 33075714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is Lipid Metabolism of Value in Cancer Research and Treatment? Part II: Role of Specialized Pro-Resolving Mediators in Inflammation, Infections, and Cancer.
    Babar MU; Nassar AF; Nie X; Zhang T; He J; Yeung J; Norris P; Ogura H; Muldoon A; Chen L; Libreros S
    Metabolites; 2024 May; 14(6):. PubMed ID: 38921449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different origin.
    Alunno A; Carubbi F; Rodríguez-Carrio J
    RMD Open; 2020 May; 6(1):. PubMed ID: 32423970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis.
    Recchiuti A; Mattoscio D; Isopi E
    Front Pharmacol; 2019; 10():252. PubMed ID: 31001110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of peroxisome proliferator-activated receptors in the modulation of hyperinflammation induced by SARS-CoV-2 infection: A perspective for COVID-19 therapy.
    Hasankhani A; Bahrami A; Tavakoli-Far B; Iranshahi S; Ghaemi F; Akbarizadeh MR; Amin AH; Abedi Kiasari B; Mohammadzadeh Shabestari A
    Front Immunol; 2023; 14():1127358. PubMed ID: 36875108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Roles of Specialized Pro-Resolving Lipid Mediators in Autophagy and Inflammation.
    Recchiuti A; Isopi E; Romano M; Mattoscio D
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32927853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
    Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discrimination of COVID-19 From Inflammation-Induced Cytokine Storm Syndromes Using Disease-Related Blood Biomarkers.
    Kessel C; Vollenberg R; Masjosthusmann K; Hinze C; Wittkowski H; Debaugnies F; Nagant C; Corazza F; Vély F; Kaplanski G; Girard-Guyonvarc'h C; Gabay C; Schmidt H; Foell D; Tepasse PR
    Arthritis Rheumatol; 2021 Oct; 73(10):1791-1799. PubMed ID: 33880885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel definition and treatment of hyperinflammation in COVID-19 based on purinergic signalling.
    Hasan D; Shono A; van Kalken CK; van der Spek PJ; Krenning EP; Kotani T
    Purinergic Signal; 2022 Mar; 18(1):13-59. PubMed ID: 34757513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pro resolving inflammatory effects of the lipid mediators of omega 3 fatty acids and its implication in SARS COVID-19.
    Regidor PA; Santos FG; Rizo JM; Egea FM
    Med Hypotheses; 2020 Dec; 145():110340. PubMed ID: 33069094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the SARS-CoV-2 Cytokine Storm.
    Torabi-Rahvar M; Rezaei N
    Curr Pharm Des; 2021; 27(13):1549-1552. PubMed ID: 33238863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specialized pro-resolving mediators in cardiovascular diseases.
    Fredman G; Spite M
    Mol Aspects Med; 2017 Dec; 58():65-71. PubMed ID: 28257820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants.
    Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
    Microbiol Spectr; 2022 Feb; 10(1):e0150421. PubMed ID: 34985303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.